
Bob Paulson discusses the importance of building a reimbursement strategy and driving physician adoption in the medical device industry.
In this episode of Medsider Radio , we sat down with Bob Paulson , President and CEO of Sonex Health . Sonex’s UltraGuideCTR device is a minimally invasive technology that enables ultrasound-guided carpal tunnel release procedures to be performed outside the surgical suite using local anesthesia, expanding patient access and reducing the cost of care. Before joining Sonex, Bob led multiple venture-backed medical device companies through commercialization, including NxThera, acquired by Boston Scientific, Restore Medical, acquired by Medtronic, and VentureMed Group. Earlier in his career, he held senior leadership roles at Medtronic, Advanced Bionics, and Endocardial Solutions, which was acquired by St. Jude Medical. In this interview, Bob explains how to build a reimbursement strategy before your first clinical study, drive physician adoption when introducing a new care pathway, and raise capital aligned with value inflection points. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter…
Host: Scott Nelson
Guest: Bob Paulson
Organizations: Sonex Health, Boston Scientific, Medtronic, Advanced Bionics, Endocardial Solutions, St. Jude Medical, Medsider
Products: UltraGuideCTR
Explore listener stats, chart rankings, contacts and more on the Medsider: Learn from Medtech and Healthtech Founders and CEOs podcast page.